Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | L5229 | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | PJ353 | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | SYR |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | SYR |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | IM / RA |
he developed blisters on his left wrist and palm; he had nerve pain; his left hand swelled and the swelling is getting worse; numbness up the back of his left arm from armpit to palm.; This non-serious case was reported by a consumer via call center representative and described the occurrence of blister in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. Concomitant products included tiotropium bromide monohydrate (Spiriva). On 09-JUL-2025, the patient received the 1st dose of Shingrix (intramuscular, right arm) and Boostrix (intramuscular, left arm). On 13-JUL-2025, 4 days after receiving Shingrix and Boostrix, the patient experienced blister (Verbatim: he developed blisters on his left wrist and palm), nerve pain (Verbatim: he had nerve pain), swelling (Verbatim: his left hand swelled and the swelling is getting worse) and numbness in hand (Verbatim: numbness up the back of his left arm from armpit to palm.). The patient was treated with gabapentin. On 27-JUL-2025, the outcome of the blister was resolved (duration 14 days). The outcome of the nerve pain, swelling and numbness in hand were not resolved. It was unknown if the reporter considered the blister, nerve pain, swelling and numbness in hand to be related to Shingrix and Boostrix. It was unknown if the company considered the blister, nerve pain, swelling and numbness in hand to be related to Shingrix and Boostrix. Additional Information: GSK Receipt Date: 03-SEP-2025 The reporter was patient itself. The patient mentioned that the nerve pain and numbness were worsening. The gabapentin did not relieve the nerve pain and numbness after giving it as treatment. The patient left hand swollen and the swelling was getting worse.
SPIRIVA